Transcription of DCPAR for Ampicillin-Salbactam 1 g--0 5 and 2 g-1 g ...
{{id}} {{{paragraph}}}
PAR Ampicillin/Sulbactam 1 g and 2 g/1 g powder for Solution for Injection or Infusion UK/H/4322/001-2/DC 1 Public Assessment Report Decentralised Procedure Ampicillin/Sulbactam 1 g and 2 g/1 g Powder for Solution for Injection or Infusion Ampicillin sodium and Sulbactam sodium UK/H/4322/001-2/DC UK licence no: PL 28176/0047-8 Strides Arcolab International Limited PAR Ampicillin/Sulbactam 1 g and 2 g/1 g powder for Solution for Injection or Infusion UK/H/4322/001-2/DC 2 Ampicillin/Sulbactam 1 g and 2 g/1 g Powder for Solution for Injection or Infusion PL 28176/0047-8 LAY SUMMARY On 24th May 2012, Austria, Bulgaria, Czech Republic, Germany, Italy, Poland, Slovak Republic and the United Kingdom agreed to grant marketing authorisations to Strides Arcolab International Limited for medicinal products Ampicillin/Sulbactam 1 g and 2 g/1 g Powder for Solution for Injection or Infusion.
PAR Ampicillin/Sulbactam 1 g/0.5 g and 2 g/1 g powder for Solution for Injection or Infusion UK/H/4322/001-2/DC 1 Public Assessment Report Decentralised Procedure
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}